ICON

ICON Public Limited Company is a global contract research organization that offers outsourced development services to the pharmaceutical, biotechnology, and medical device sectors. Established in 1990 and headquartered in Dublin, Ireland, ICON specializes in the strategic development, management, and analysis of programs that support all phases of the clinical development process, from compound selection to Phase I-IV clinical studies. The company provides a comprehensive range of services, including product development planning, clinical pharmacology, patient recruitment and retention, project management, and data management. Additionally, ICON offers ancillary services such as medical imaging, biostatistics, pharmacovigilance, and regulatory support. Its capabilities extend to adaptive and virtual trial services, as well as research trials for government agencies, making it a versatile partner for firms navigating the complexities of drug development and clinical trials.

Miroslav Apostolov

Senior Clinical Research Associate

Nigel Clerkin

CFO

John Climax

Co-Founder

Martine Dehlinger-Kremer

Vice President Scientific Affairs, Pediatric Subject Matter Expert - Center Pediatric Clinical Dev

Michael Forstner

Senior Director Patient Safety

David Hinds

General Partner

Kevon Kothari

Vice President, Corporate Development and Innovation

Rany Swanson

SVP, Connected Health and President, Care Innovations

20 past transactions

PRA International

Acquisition in 2021
PRA International is a prominent contract research organization that offers outsourced clinical development and data solution services to the pharmaceutical and biotechnology industries worldwide. The company operates through two primary segments: Clinical Research and Data Solutions. The Clinical Research segment provides comprehensive services including clinical trial management, regulatory affairs, and therapeutic expertise, along with early development services for Phase I and IIa studies. The Data Solutions segment focuses on delivering data analytics, consulting, and technology-enabled solutions to the life sciences market. With over 10,000 employees across more than 80 countries, PRA is involved in conducting clinical trials for various therapeutic areas, including oncology and immunology. The organization plays a significant role in drug development, having contributed to the regulatory approval of numerous marketed drugs. PRA International, founded in 1976 and headquartered in Raleigh, North Carolina, is committed to excellence and innovation in its partnerships with clients.

MedPass International

Acquisition in 2020
MedPass International SAS is a prominent medical device contract research organization (CRO) and consultancy based in Paris, France. Founded in 1991, the company specializes in providing strategic consulting, regulatory affairs, reimbursement strategies, clinical operations, biometrics, and legal representation services. MedPass is recognized for its expertise in aiding the development of innovative medical device technologies, offering a comprehensive suite of services designed to meet the diverse needs of clients worldwide. As of January 31, 2020, it operates as a subsidiary of ICON Public Limited Company.

MeDiNova Limited

Acquisition in 2019
MeDiNova Limited provides clinical research and medical services. The company was incorporated in 2000 and is based in Coventry, United Kingdom. As of May 23, 2019, MeDiNova Limited operates as a subsidiary of ICON Public Limited Company.

MolecularMD

Acquisition in 2019
MolecularMD Corporation is a company that develops and commercializes specialty molecular diagnostics specifically for oncology applications. Founded in 2005 and based in Portland, Oregon, with an additional location in Cambridge, Massachusetts, the company focuses on enabling the precise selection, monitoring, and management of patients undergoing treatment with molecularly targeted cancer therapies. MolecularMD offers a range of services, including assay design and development, clinical trial support, regulatory planning, and custom clinical kit manufacturing. Its assays leverage both established and innovative technologies to deliver sensitive and reliable results that aid in the clinical development, regulatory approval, and commercialization of new anticancer agents. MolecularMD operates as a subsidiary of ICON Laboratory Services Inc.

Mapi

Acquisition in 2017
Mapi is a prominent Patient-Centered Research company that has been serving academia, life science researchers, and the pharmaceutical industry for over 40 years. Founded in 1974, Mapi focuses on understanding the complete ecosystem of patients, including healthcare professionals, patient communities, payers, and regulators. The company's expertise encompasses Real-World Evidence and post-approval research services, along with consulting and publishing efforts aimed at promoting patient-centric methodologies. Mapi is recognized for its significant contributions to the field, positioning itself as a leader in the pursuit of insights into patient treatment complexities. Through its commitment to patient-focused research, Mapi continues to drive advancements in treatment processes and healthcare solutions.

Clinical Research Management

Acquisition in 2016
ClinicalRM is a full-service Contract Research Organization specializing in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs and devices. The organization helps customers get their products to market faster with a wide array of research, regulatory and sponsor services within the U.S. and around the globe. From international partnerships and affiliations to government relations and local alliances, ClinicalRM delivers a synergy in the global market with projects spanning the government, academic and commercial marketplaces. The company has a distinct ability to provide boots-on-the-ground and rapid response efforts to global health crises.

PMG Research

Acquisition in 2015
PMG Research, Inc. is a clinical research organization based in Winston-Salem, North Carolina, specializing in conducting clinical trials across various therapeutic areas, including asthma, COPD, type 2 diabetes, cardiovascular diseases, and more. Founded in 1979, PMG Research operates a network of facilities located in multiple cities across the United States, including Tennessee, South Carolina, and Illinois. The organization has successfully conducted over 7,700 research studies for numerous pharmaceutical sponsors and contract research organizations (CROs), demonstrating extensive experience in all phases of clinical trials. By providing exceptional services tailored to the needs of its sponsors and participants, PMG Research plays a vital role in advancing medical research and treatment options. As of 2015, it operates as a subsidiary of ICON Clinical Research Limited.

MediMedia Pharma Solutions

Acquisition in 2015
MediMedia Managed Markets provides you with the best strategic expertise available in the industry. Their large staff of managed markets strategists, researchers, MDs, PharmDs, and MPHs, all proven experts in the field, will help.

Aptiv Solutions

Acquisition in 2014
Aptiv Solutions, Inc. is a clinical research organization that specializes in providing a range of clinical trial services primarily for biotechnology and pharmaceutical companies. The company offers adaptive trial design, simulation, and execution, as well as early phase development consulting and preclinical development. Additionally, Aptiv Solutions provides regulatory compliance consulting, including strategy development, agency advisory, legal representation, and submission management. Its therapeutic services extend to oncology, cardiology, dermatology, respiratory conditions, and orphan diseases. The company also developed AptivAdvantage, an integrated technology platform designed to facilitate adaptive clinical trials. Founded in 1983 and initially known as Averion International Corp., Aptiv Solutions is headquartered in Reston, Virginia, with an additional office in Durham, North Carolina.

Cross Country Healthcare - Clinical Trial Services

Acquisition in 2013
Cross Country Healthcare - Clinical Trial Services provides resourcing providers, ClinForce and Assent Consulting.

PriceSpective

Acquisition in 2012
PriceSpective is a value strategy consultancy that defines, drives, and captures value for pharmaceutical and biotechnology clients in today's complex healthcare environment. The company delivers expert guidance in integrated global pricing, reimbursement and market access strategy with its depth of experience and actively engaged senior leadership. PriceSpective is headquartered in Philadelphia with offices in London, Los Angeles, San Diego, Raleigh and Boston.

BeijingWits Medical Consulting Ltd.

Acquisition in 2011
Beijing Wits Medical Consulting Company was founded in 1997. The company provides services to global and local pharmaceutical, medical device and biotechnology companies focusing on Phase I to IV Clinical studies. Beijing Wits currently has more than 100 employees, operating from 6 offices in China.

Firecrest Clinical

Acquisition in 2011
Firecrest Clinical Ltd specializes in site performance management solutions aimed at enhancing compliance and consistency for pharmaceutical companies. The company offers a range of services, including clinical investigator training and support for medical studies. By providing outsourced development services, Firecrest Clinical caters to the needs of the pharmaceutical, biotechnology, and medical device industries, helping them streamline their clinical operations and improve overall study performance.

Oxford Outcomes

Acquisition in 2011
Oxford Outcomes provides specialist services in the fields of patient reported outcomes (PRO), health economics, epidemiology and translation and linguistic validation.

Timaq Medical Imaging

Acquisition in 2010
Timaq Medical Imaging is a Swiss-based company that specializes in advanced imaging services tailored for pharmaceutical and biotechnology firms. The company supports the clinical trial process by providing essential imaging services that aid in the evaluation and development of medical products. Timaq's expertise is particularly valuable in the context of clinical studies, where accurate imaging is critical for assessing treatment efficacy and safety. By serving the pharmaceutical, biotech, and contract service sectors, Timaq Medical Imaging plays a significant role in enhancing the quality and reliability of clinical research involving medical imaging.

Veeda Laboratories Ltd.

Acquisition in 2009
Veeda Laboratories Ltd is a specialist provider of biomarker laboratory services to global pharmaceutical and biotechnology industries.

Prevalere Life Sciences

Acquisition in 2008
Prevalere Life Sciences, Inc. is a contract research organization that specializes in providing consulting and analytical testing services compliant with Good Laboratory Practice (GLP) and current Good Manufacturing Practice (cGMP). The company offers a range of bio-analytical and immunoassay laboratory services, including chemical analysis, data analysis, and offsite staffing. Prevalere primarily serves the pharmaceutical and biotechnology sectors, delivering comprehensive support to meet the rigorous demands of these industries.

Barton & Polansky Associates, Inc.

Acquisition in 2002
Barton & Polansky Associates, Inc is specialises in clinical research services for immuno-suppressant drugs.

UCT (U.S.), Inc

Acquisition in 2000
UCT (U.S.), Inc provides central laboratory services for clinical trials to the pharmaceutical and biotechnology industries.

Pacific Research Associates, Inc.

Acquisition in 2000
Pacific Research Associates, Inc is specialising in data management statistical analysis and medical and regulatory consulting.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.